They say they will responsibly report to the relevant bodies in accordance with prevailing standards and guidelines.
We use Google Cloud Translation Services. Google requires we provide the following disclaimer relating to use of this service:
This service may contain translations powered by Google. Google disclaims all warranties related to the translations, expressed or implied, including any warranties of accuracy, reliability, and any implied warranties of merchantability, fitness for a particular purpose, and noninfringement.
Pharmaceutical professionals in Palpa have expressed their commitment to future reporting of drug vigilance and adverse effects at the community level.
The pharmaceutical professionals made this commitment after a discussion and interaction on 'Pharmacological vigilance and adverse drug effect reporting' organized by Tansen Municipality and co-organized by the Pharmaceutical Professionals Association, Palpa.
Tansen Municipality Health Branch Chief Jhabindra Neupane said that a declaration has also been issued for the first time at the community level to report adverse drug effects.
Pharmacists working in hospitals, government, private and drug stores, health workers, and health workers working at health posts in Palpa participated in the program.
Participants from different areas of the district declared that they have acquired the necessary knowledge and skills related to the safe use of drugs, identification and management of adverse effects, and the reporting system for adverse drug effects. Tansen Municipality Public Health Inspector Chandratara Basyal said that the participants responded that they had gained a clear understanding of the process of identifying, classifying, risk assessment and reporting adverse effects that may occur after using the medicine to the relevant agencies in a timely manner.
The participants said that they will responsibly report any adverse effects of the medicine seen within their work area, community pharmacy or hospital pharmacy to the relevant agencies in accordance with the prevailing standards and guidelines.
Buddhibal Chidi, an officer working in the Department of Medicines Management and a researcher at Pokhara University, said that they are committed to playing an active role in promoting the safe and rational use of medicines and ensuring patient safety. He said that he is going to conduct a model exercise in the district for research while studying at the master's level in clinical pharmacy and whether it can be taken forward.
Sanjay Subedi, an associate professor at Pokhara University, said that the topic of safe use of medicines and its impact on the community is a new practice for Nepal. "Such a process has been going on abroad for a long time," he said, "but in Nepal, there has been no research on the impact it has had at the community level. There is no practice of reporting either. Now, after conducting research, we will get information on how to move forward."
Tansen Municipality Chief Administrative Officer Chetnath Giri said that although the program was started in Palpa as a model, the Department of Drug Management should take the initiative to expand it to all districts. Nepal Pharmaceutical Professionals Association Palpa President Samir Man Singh said that since this is the first time a new type of program has been implemented in the district, there is a need for its continuation.
